ENDOSPAN RECEIVES ADDITIONAL $25M FROM ARTIVION FOR NEXUS FDA APPROVAL PATH
HERZELIA,
"We're excited to progress in our IDE study with the FDA and extending options for more patients with aortic arch disease through this agreement with Artivion,"
More than 120,000 patients suffer thoracic aortic arch disease every year in the
Endospan has developed NEXUS, the first and only approved branched endovascular system to treat aortic arch disease, including both aortic aneurysms and aortic dissections. While minimally invasive endovascular repair has been the standard of care for Abdominal Aortic Aneurysm (AAA) and Thoracic Aortic Aneurysm (TAA), aortic arch disease patients with aneurysms or dissections who receive treatment have previously had little choice but to undergo open-chest surgery with its associated invasiveness and risks, lengthy hospitalizations, and prolonged recuperation. NEXUS transforms a complex surgical aortic arch repair into a minimally invasive endovascular procedure. NEXUS addresses a
Endospan is currently enrolling patients in the TRIOMPHE IDE Study, a multi-arm, multi-center, non-randomized, prospective, clinical study to evaluate the safety and effectiveness of NEXUS® in treating thoracic aortic lesions involving the aortic arch. The study will enroll up to 110 patients at up to 31 sites. Earlier this year, Endospan shared 30-day results of the first 22 patients enrolled in the study. This early data aligned with results achieved during an EU clinical study, suggesting that NEXUS may provide surgeons with a straightforward, minimally invasive solution for aortic arch repair that allows for procedural consistency with reliable patient outcomes.
About Endospan Ltd.
Privately held Endospan, headquartered in Herzelia (
About Artivion, Inc.
Headquartered in suburban
Endospan
Chief Financial Officer
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/endospan-receives-additional-25m-from-artivion-for-nexus-fda-approval-path-302188007.html
SOURCE Endospan
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HOT CHILI ANNOUNCES RESULTS OF THE GENERAL MEETING HELD 4 JULY 2024
- 3.2 billion smart payment cards and modules shipped in 2023 by SPA [1]
- Hyperlink InfoSystem Emerges as India's #1 Salesforce Development Company in 2024
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!